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Chronic wasting disease (CWD) of deer and elk is
endemic in a tri-corner area of Colorado, Wyoming, and
Nebraska, and new foci of CWD have been detected in
other parts of the United States. Although detection in some
areas may be related to increased surveillance, introduc-
tion of CWD due to translocation or natural migration of ani-
mals may account for some new foci of infection.
Increasing spread of CWD has raised concerns about the
potential for increasing human exposure to the CWD agent.
The foodborne transmission of bovine spongiform
encephalopathy to humans indicates that the species bar-
rier may not completely protect humans from animal prion
diseases. Conversion of human prion protein by CWD-
associated prions has been demonstrated in an in vitro cell-
free experiment, but limited investigations have not
identified strong evidence for CWD transmission to
humans. More epidemiologic and laboratory studies are
needed to monitor the possibility of such transmissions.
C
hronic wasting disease (CWD) is classified as a trans-
missible spongiform encephalopathy (TSE), or prion
disease, along with other animal diseases, such as scrapie
and bovine spongiform encephalopathy. The only known
natural hosts for CWD are deer (Odocoileus species) and
Rocky Mountain elk (Cervus elaphus nelsoni) (1,2). CWD
and other TSEs are believed to be caused by a pathogenic
effect on neurons of an abnormal isoform of a host-encod-
ed glycoprotein, the prion protein. The pathogenic form of
this protein appears to be devoid of nucleic acids and sup-
ports its own amplification in the host. TSEs in animals
primarily occur by transmitting the etiologic agent within
a species, either naturally or through domestic husbandry
practices. In contrast, most such encephalopathies in
humans occur as a sporadic disease with no identifiable
source of infection or as a familial disease linked with
mutations of the prion protein gene (3). A notable excep-
tion among the human TSEs is the variant form of
Creutzfeldt-Jakob disease (vCJD), which is believed to
have resulted from the foodborne transmission of bovine
spongiform encephalopathy (BSE) to humans (4,5).
CWD was first identified as a fatal wasting syndrome
of captive mule deer in the late 1960s in research facilities
in Colorado and was recognized as a TSE in 1978 (6,7).
Subsequently, this wasting disease was identified in mule
deer in a research facility in Wyoming and in captive elk
in both the Colorado and Wyoming facilities (6–8). The
disease was first recognized in the wild in 1981, when it
was diagnosed in a free-ranging elk in Colorado (1,9). By
the mid-1990s, CWD had been diagnosed among free-
ranging deer and elk in a contiguous area in northeastern
Colorado and southeastern Wyoming, where subsequent
surveillance studies confirmed it to be endemic (10).
Epidemic modeling suggested that this wasting disease
might have been present among free-ranging animals in
some portions of the disease-endemic area several
decades before it was initially recognized (10). On the
basis of hunter-harvested animal surveillance, the overall
prevalence of the disease in this area from 1996 through
1999 was estimated at approximately 5% in mule deer,
2% in white-tailed deer, and <1% in elk (10). In 2000, sur-
veillance data indicated that the disease-endemic focus
extended eastward into adjacent areas of Nebraska (1,11),
and ongoing surveillance continues to redefine the limits
of this focus.
Clinical manifestations of CWD include weight loss
over weeks or months, behavioral changes, excessive sali-
vation, difficulty swallowing, polydipsia, and polyuria
(1,6–8). In some animals, ataxia and head tremors may
occur. Most animals with the disease die within several
months of illness onset, sometimes from aspiration pneu-
monia. In rare cases, illness may last for >1 year. In cap-
tive cervids, most cases occur in animals 2–7 years of age;
however, the disease has been reported in cervids as young
as 17 months and as old as >15 years of age (1). This dis-
ease can be highly transmissible within captive deer and
elk populations. A prevalence of >90% was reported
among mule deer in facilities where the disease has been
endemic for >2 years (2,6,7,12). The mode of transmission
among deer and elk is not fully understood; however,
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mal-to-animal contact or as a result of indirect exposure to
the causative agent in the environment, including contam-
inated feed and water sources (12).
Geographic Distribution of 
Chronic Wasting Disease
The geographic extent of CWD has changed dramati-
cally since 1996 (2). Two largely independent and simulta-
neous epidemics, one in free-ranging deer and elk and
another in the captive elk and deer industry, appear to rep-
resent the main framework for explaining the disease’s
current distribution (2). More extensive and coordinated
surveillance has provided a clearer picture of its distribu-
tion over the last few years. Since 2000, the disease in free-
ranging cervids has been increasingly identified outside of
the original CWD-endemic areas of Colorado and
Wyoming (Figure). The observed distribution seems to be
related in part to natural movement of deer and elk and to
commercial movement of infected animals to areas far
from the disease-endemic zone. Considerable attention has
been given to recent increases in the geographic spread of
the disease, which in some areas is likely a result of
increased surveillance rather than evidence of explosive
geographic spread.
No single original event or source links all wasting dis-
ease foci documented to date. Given the disease’s insidious
nature and the apparent duration (at least several decades)
of epidemics among captive and free-ranging cervids, gaps
in knowledge about its spread and distribution are not sur-
prising, particularly within the captive deer and elk indus-
try. However, our current knowledge cannot explain some
of the distinct foci of CWD among free-ranging animals
(e.g., in New Mexico and Utah). Thus, unidentified risk
factors may be contributing to the occurrence of CWD
among free-ranging and captive cervid populations in
some areas.
Chronic Wasting Disease in 
Free-ranging Deer and Elk  
In 2000, surveillance of hunter-harvested deer first
detected the occurrence of CWD in counties in southwest-
ern Nebraska, adjacent to the previously recognized areas
of Colorado and Wyoming that are endemic for this dis-
ease (Figure) (1,11). It was reported subsequently in other
Nebraska counties, including among deer and elk in a
commercial, large enclosure surrounded by a fence in
northwestern Nebraska, where the prevalence of CWD
was >50% (11). Free-ranging deer from areas surrounding
the enclosure also tested positive for the disease but at sub-
stantially lower rates. In 2001, CWD in a free-ranging deer
was identified in the southwestern part of South Dakota
along the Nebraska border close to an area where the dis-
ease had been reported among captive elk (13). Since then,
additional CWD-positive free-ranging deer and elk have
been identified in southwestern South Dakota.  
CWD in free-ranging cervids was first reported east of
the Mississippi River in Wisconsin among white-tailed
deer harvested in the 2001 hunting season (14).
Subsequent surveillance indicated that this CWD epidem-
ic focus was limited to several counties in the south-central
region of Wisconsin, although a second focus spanning the
Illinois border was also detected (15). The absence of evi-
dence for a widespread occurrence of CWD and its low
prevalence, despite a highly dense deer population, indi-
cate that the disease probably was recently introduced into
Wisconsin. Because the distance from the CWD-endemic
area of Colorado-Wyoming effectively precludes eastward
migration of animals as a logical source of infection, CWD
in Wisconsin was more likely introduced by an imported
infected cervid or some other unidentified source (14). The
proximity of the Wisconsin-Illinois focus to a white-tailed
deer farm with infected animals appears to support this
explanation, as highlighted by the report of CWD in a pre-
viously captive white-tailed deer approximately 7 months
after it escaped into the wild in southern Wisconsin (14).
The disease among the captive deer herd from which the
white-tailed deer escaped was demonstrated earlier, when
a still-captive deer tested positive for the disease. The cap-
tive source herd was held in a facility 30–50 km from the
Illinois location where CWD was recently identified in a
free-ranging deer (16). In 2002, the Wisconsin Department
of Natural Resources launched an ambitious culling pro-
gram by providing special hunting permits to eliminate the
disease in a designated “eradication zone” around the areas
where it was detected (15,17). Whether such aggressive
management will succeed in eliminating free-ranging foci
of CWD remains to be determined.
In Colorado, the Continental Divide initially appeared
to have prevented natural expansion of CWD into the
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Figure. Chronic wasting disease among free-ranging deer and elk
by county, United States.western part of the state. However, in 2002, the disease
was confirmed for the first time in several free-ranging
deer harvested in western Colorado in an area surrounding
a commercial enclosure, where entrapped mule deer test-
ed positive for CWD. Aggressive culling of deer and elk
surrounding the enclosure was initiated to prevent further
spread of the disease in the western slope of Colorado.
Through the 2002 hunting season, CWD-positive deer and
elk continued to be identified outside of the previously
defined disease-endemic area, primarily in northwestern
Colorado (18). This northwestern focus appears to be dis-
continuous from the previously identified CWD-endemic
area, although surveys conducted in 2002 demonstrated
that the western and southern boundaries of that area were
wider than previously believed. The ultimate source of
this wasting disease in northwestern Colorado remains
unidentified.
In 2002, samples from an emaciated, free-ranging mule
deer found in White Sands, New Mexico, tested positive
for CWD (1,19). No cervids have been held in captivity
close to the area where the New Mexico deer was found,
and the origin of the disease in this deer remains unknown.
In addition, CWD-positive, free-ranging deer have been
identified in Wyoming to the west over the Continental
Divide from the known CWD-endemic zone (20). In 2003,
a mature buck deer harvested in the fall of 2002 in north-
eastern Utah tested positive for the disease (21); addition-
al cases have since been found in central and eastern Utah
(Figure). These cases provide additional evidence for the
potential spread of this wasting disease in the wild.
In Canada, CWD was first detected in free-ranging
cervids (two mule deer) in 2001 in Saskatchewan; a few
additional deer tested positive in 2002 and 2003 (22).
Saskatchewan Environment has implemented a herd-
reduction program using “control permits” to prevent fur-
ther spread of the disease among free-ranging cervids.
Chronic Wasting Disease in 
Captive Deer and Elk
CWD was first recognized in the captive elk industry in
Saskatchewan in 1996, but subsequent investigations indi-
cated that the most likely source of Canadian cases was
captive elk imported from South Dakota prior to 1989
(2,22). Since 1996, surveillance has detected infected ani-
mals on more than 25 elk farms in Colorado, Kansas,
Minnesota, Montana, Nebraska, Oklahoma, South Dakota,
and Alberta, Canada, and the Republic of Korea
(1,14,23,24). CWD in most of these farms was identified
in the past 5 years. In 2002, the disease was detected in
white-tailed deer on farms in Alberta and Wisconsin
(23,25). More extensive and uniform surveillance in cap-
tive white-tailed deer is needed to determine the full extent
of the disease in this industry.
Captive herds with a CWD-infected cervid are often
depopulated both in Canada and the United States.
Carcasses of depopulated animals are incinerated or buried
in accordance with local regulations. Meat from depopu-
lated animals has not been allowed to enter the human food
and animal feed supply.
Transmission to Other Animals
Concerns have been raised about the possible transmis-
sion of the CWD agent to domestic animals, such as cattle
and sheep, which may come in contact with infected deer
and elk or CWD-contaminated environments. If such
transmissions were to occur, they would potentially
increase the extent and frequency of human exposure to
the CWD agent. In addition, passage of the agent through
a secondary host could alter its infectious properties,
increasing its potential for becoming more pathogenic to
humans. This phenomenon may have occurred with BSE
when a strain of scrapie, a possible original source of the
BSE outbreak, changed its pathogenic properties for
humans after infecting cattle. However, the exact origin of
BSE remains unknown. 
Although CWD does not appear to occur naturally out-
side the cervid family, it has been transmitted experimen-
tally by intracerebral injection to a number of animals,
including laboratory mice, ferrets, mink, squirrel mon-
keys, and goats (1,26). In an experimental study, the CWD
agent was transmitted to 3 of 13 intracerebrally injected
cattle after an incubation period of 22 to 27 months (27).
The susceptibility of cattle intracerebrally challenged with
the agent of this disease was substantially less than that
observed after intracerebral scrapie challenge: nine of
nine cattle succumbed to scrapie challenge after intracere-
bral injection (28). In ongoing experimental studies, after
>6 years of observation, no prion disease has developed in
11 cattle orally challenged with the CWD agent or 24 cat-
tle living with infected deer herds (E.S. Williams and
M.W. Miller, unpub. data) (1). In addition, domestic cat-
tle, sheep, and goat residing in research facilities in close
contact with infected cervids did not develop a prion dis-
ease. 
Analysis by immunohistochemical studies of the tissue
distribution of prions in CWD-infected cervids identified
the agent in the brain, spinal cord, eyes, peripheral nerves,
and lymphoreticular tissues (Table 1) (29,30). Distribution
of the CWD agent outside of the brain seems to be less
widespread in elk than in deer (2). Involvement of the ton-
sils and peripheral nerves early in the course of experimen-
tal and natural prion infection suggests the possible
involvement of the lymphoreticular and peripheral nervous
systems in the pathogenesis and transmission of the dis-
ease (2,12,30,31). 
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Epidemiologic Studies
The increasing detection of CWD in a wider geograph-
ic area and the presumed foodborne transmission of BSE to
humans, resulting in cases of vCJD, have raised concerns
about the possible zoonotic transmission of CWD (32). In
the late 1990s, such concerns were heightened by the occur-
rence of CJD among three patients <30 years of age who
were deer hunters or ate deer and elk meat harvested by
family members (Table 2). However, epidemiologic and
laboratory investigations of these case-patients indicated no
strong evidence for a causal link between CWD and their
CJD illness (33). None of the patients were reported to have
hunted deer or eaten deer meat harvested in the CWD-
endemic areas of Colorado and Wyoming. Such a history in
unusually young CJD patients, if present, would have sup-
ported a causal link with CWD. Moreover, the testing of
brain tissues from >1,000 deer and elk harvested from areas
where the patients hunted or their venison originated did
not show any evidence of CWD (33). In addition, the lack
of homogeneity in the clinicopathologic manifestation and
codon 129 of the prion protein gene among the three
patients suggested that their illnesses could not be
explained by exposure to the same prion strain. In vCJD,
homogeneity of the genotype at codon 129 and the clinical
and pathologic phenotype were attributed to the patients’
exposure to the same prion strain, the agent of BSE.
In 2001, the case of a 25-year-old man who reportedly
died of a prion disease after an illness lasting ≈22 months
was investigated (Table 2). Although this man had hunted
deer only rarely, his grandfather hunted deer and elk
throughout much of the 1980s and 1990s and regularly
shared the venison with the case-patient’s family. The
grandfather primarily hunted in southeastern Wyoming,
around the known CWD-endemic area. The case-patient’s
illness began with a seizure and progressed to fatigue, poor
concentration, and depression. Memory loss, ataxia,
speech abnormalities, combative behavior, and recurrent
seizures also developed. Histopathologic, immunohisto-
chemical, and Western blot testing of brain autopsy sam-
ples confirmed a prion disease diagnosis. Analysis of the
prion protein gene indicated a P102L mutation coupled
with valine at the polymorphic codon 129 in the mutant
allele, confirming a diagnosis of Gerstmann-Str@ussler-
Scheinker syndrome (GSS). This case-patient was unusu-
ally young even for a person with a GSS P102L mutation.
It remains unknown whether the possible exposure of the
case-patient to CWD-infected venison potentially con-
tributed to the early onset of his prion disease.
In 2001, two additional CJD patients 26 and 28 years of
age were reported from a single state (Table 2) (34). The
patients grew up in adjacent counties and had illness onset
within several months of each other. As a result of this fact
and their unusually young age, a possible environmental
source of infection, including exposure to CWD-infected
venison, was considered. One of the patients died after an
illness lasting 5–6 months that was characterized by pro-
gressive aphasia, memory loss, social withdrawal, vision
disturbances, and seizure activity leading to status epilep-
ticus and induced coma. Histopathologic, immunohisto-
chemical, and Western blot testing of brain biopsy and
autopsy samples confirmed a CJD diagnosis. The patient’s
disease phenotype corresponded to the MM2 sporadic CJD
subtype reported by Parchi et al. (35). This patient did not
hunt, and family members provided no history of regular-
ly eating venison. The patient may have occasionally eaten
venison originating from the Upper Peninsula of Michigan
while away from home during his college years. However,
ongoing surveillance has not detected CWD in Michigan
deer (36).
The second patient died from an illness lasting ≈16
months. The patient’s illness began with behavioral
changes, including unusual outbursts of anger and depres-
sion. Confusion, memory loss, gait disturbances, inconti-
nence, headaches, and photophobia also developed.
Western blot analysis of frozen brain biopsy tissue con-
firmed a prion disease diagnosis. Immunohistochemical
analysis of brain tissue obtained after the patient’s death
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Table 1. Deer tissues tested for the CWD agent by animal 
bioassay or immunohistochemical studies
a 




Eyes (optic nerve, ganglion cells, retina) 
Tonsils 
Lymphoid tissues (e.g., gut-associated, retropharyngeal, 
posterior nasal septum) 
Spleen 
Pancreas 
Peripheral nerves (e.g., brachial plexus, sciatic nerve, 
vagosympathetic trunk) 
Tissues negative for CWD agent 
Dorsal root ganglia 
Parotid and mandibular salivary glands, tongue, esophagus, 
small intestine, colon 
Thymus 
Liver 
Kidneys, urinary bladder, ovary, uterus, testis, epididymis, 
placentomes 
Myocardium, Purkinje fibers, arteries, veins 
Trachea, bronchi, bronchioles, aleveolar parenchyma 
Bone marrow 
Thyroid gland, adrenal gland 
Skeletal muscle 
Skin 
aCWD, chronic wasting disease. showed prion deposition consistent with GSS. Aprion pro-
tein gene analysis could not be performed because appro-
priate samples were lacking. However, prion protein gene
analysis of a blood sample from one of the patient’s par-
ents indicated a GSS P102L mutation. The patient did not
hunt but may have eaten venison from Michigan once
when he was 1–2 years old. The GSS diagnosis greatly
reduced the likelihood that the two patients reported from
adjacent counties had disease with a common origin. 
Recently, rare neurologic disorders resulting in the
deaths of three men who participated in “wild game feasts”
in a cabin owned by one of the decedents created concern
about the possible relationship of their illnesses with CWD
(Table 2) (37). Two of the patients reportedly died of CJD,
and the third died from Pick’s disease. More than 50 per-
sons were identified as possibly participating in these
feasts; the three patients were the only participants report-
ed to have died of a degenerative neurologic disorder.
Reanalysis of autopsy brain tissues from the three patients
at the National Prion Disease Pathology Surveillance
Center indicated that two of them had no evidence of a
prion disease by immunohistochemical analysis. CJD was
confirmed in the third patient, who had clinicopathologic,
codon 129, and prion characteristics similar to the most
common sporadic CJD subtype (MM1/MV1) (35). This
patient participated in the feasts only once, perhaps in the
mid-1980s. In addition, the investigation found no evi-
dence that the deer and elk meat served during the feasts
originated from the known CWD-endemic areas of
Colorado and Wyoming.  
In 2003, CJD in two deer and elk hunters (54 and 66
years of age) was reported (38). The report implied that the
patients had striking neuropathologic similarities and that
their illness may represent a new entity in the spectrum of
prion diseases. A third patient (63 years of age), who was
also purported to have been a big game hunter, was subse-
quently reported from the same area. However, none of the
three patients were reported to have eaten venison from the
CWD-endemic areas of the western United States. The 66-
year-old patient hunted most of his life in Washington
State. Although information about the 54-year-old patient
was limited, there was no evidence that he hunted in
CWD-endemic areas. The third patient was not a hunter
but ate venison harvested from Pennsylvania and
Washington. The neuropathologic changes, Western blot
profile, and genotype at codon 129 of the three patients
each fit the MM1, VV1, or VV2 sporadic CJD subtype,
indicating absence of phenotypic similarity among the
cases or atypical neuropathologic features (35).
To date, only two nonfamilial CJD cases with a positive
history of exposure to venison obtained from the known
CWD-endemic areas have been reported. One of the
patients was a 61-year-old woman who grew up in an area
where this disease is known to be endemic, and she ate
venison harvested locally. She died in 2000, and analysis
of autopsy brain specimens confirmed that the patient’s
CJD phenotype fit the MM1 subtype, with no atypical neu-
ropathologic features. The second patient was a 66-year-
old man who was reported to have eaten venison from two
deer harvested in a CWD-endemic area. Both deer tested
negative for CWD, and the patient’s illness was consistent
with the MM1 CJD phenotype.  
Despite the decades-long endemicity of CWD in
Colorado and Wyoming, the incidence of CJD and the age
distribution of CJD case-patients in these two states are
similar to those seen in other parts of the United States.
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Table 2. Creutzfeldt-Jakob disease investigated for possible causal link  with chronic wasting disease of deer and elk, United States
a 
Case no.  Age at death (y)  Year of death  Codon 129  Western blot  Final diagnosis 
Eating of venison from CWD-
endemic area 
1  25  2001  M/V  Type 1  GSS 102  Yes 
2  26  2001  M/M  Type 2  CJD  No 
3
b  28  2002  nd  nd  GSS 102  No 
4  28  1997  M/M  nd  CJD  No 
5  28  2000  M/V  Type 1  CJD  No 
6  30  1999  V/V  Type 1  CJD  No 
7  54  2002  V/V  Type 2  CJD  No 
8
c  55  1999  M/M  Type 1  CJD  No 
9
d  61  2000  M/M  Type 1  CJD  Yes 
10  63  2002  V/V  Type 1  CJD  No 
11
e  64  2002  M/M  Type 1  CJD  Yes 
12  66  2001  M/M  Type 1  CJD  No 
aCWD, chronic wasting disease; GSS, Gerstmann-Sträussler-Scheinker syndrome; CJD, Creutzfeldt-Jakob disease; nd, not done. 
bImmunohistochemical analysis of postmortem brain tissue was consistent with GSS, and a GSS 102 mutation was confirmed in the family. 
cInvestigated as part of a cluster of three case-patients who participated in “wild game feasts” in a cabin owned by one of the decedents. 
dPatient grew up in an area known to be endemic for CWD and ate venison harvested locally; however, the CJD phenotype fits the most common form of 
sporadic CJD. 
ePatient may have been successful in harvesting two deer since 1996 from a CWD-endemic area, but both deer tested negative for CWD. 
 From 1979 to 2000, 67 CJD cases from Colorado and 7
from Wyoming were reported to the national multiple
cause-of-death database. The average annual age-adjusted
CJD death rate was 1.2 per million persons in Colorado
and 0.8 in Wyoming. The proportion of CJD patients who
died before age 55 in Colorado (13.4%) was similar to that
of the national (10.2%). The only CJD case-patient <30
years of age in Colorado had iatrogenic CJD linked to
receipt of human growth hormone injections. CJD was not
reported in persons <55 years of age in Wyoming during
the 22-year surveillance period.
Laboratory Studies
The possible interspecies transmission of prions can be
assessed with laboratory methods. In BSE and vCJD, sev-
eral laboratory studies provided crucial evidence that
helped establish a causal link between the two diseases
(39–41). These studies characterized the molecular simi-
larities of the agents causing BSE and vCJD and deter-
mined the lesion profile and incubation period patterns of
different panels of mice inoculated by the two agents.
Limited laboratory studies have been performed to molec-
ularly characterize CWD-associated prions and to compare
them with prions from human case-patients and other
species. Strain typing studies involving wild-type inbred
mice indicated that the CWD agent from a mule deer pro-
duced incubation-period and brain-lesion profiles different
from those produced by the agents causing BSE and
scrapie (39,42). These same strain-typing techniques had
identified the similarities of the etiologic agents of BSE
and vCJD, providing strong laboratory evidence for a link
between the two diseases. 
In human prion diseases, two major types of the pro-
teinase-K–resistant prion protein fragment have been iden-
tified on the basis of their molecular size by
one-dimensional immunoblot analysis: type 1 migrating at
21 kDa and type 2 at 19 kDa (35). N-terminal protein
sequencing indicated that the cleavage site of the type 1
fragment is generally at residue 82 and that of type 2 is at
residue 97 (43). Prion strain diversity is believed to be
encoded in the three-dimensional conformation of the pro-
tein, which determines the cleavage site and molecular size
of proteinase-K–treated prion fragment, indicating that the
difference in molecular size may correlate with strain dif-
ferences. However, one-dimensional immunoblot analysis
may not identify more subtle differences that may influ-
ence the conformation of different prion strains. Analysis
of the glycoform ratios of prion fragments and application
of a two-dimensional immunoblot may help further identi-
fy these subtle differences. On one-dimensional
immunoblot analysis, the prion fragment from several
CWD-infected deer and elk migrated to 21 kDa, corre-
sponding to the type 1 pattern. This specific type has been
identified in most cases of sporadic CJD in the United
States. However, the deer and elk prion fragment differs
from that in sporadic CJD cases in the glycoform ratio. In
the CWD-associated prion fragment, the diglycosylated
form was predominant, but in the CJD-associated prions,
the monoglycosylated form was predominant. Preliminary
analysis using two-dimensional immunoblot indicated that
the CWD-associated prion fragment exhibited patterns dif-
ferent from that of the CJD-associated prion fragment from
a human patient with the type 1 pattern (S. Chen, pers.
comm.). Although analysis of more samples from cervids
and humans is needed before meaningful conclusions can
be made, these molecular techniques could potentially be
used to study the similarities or differences in prion strains
from cervids and humans with possible exposure to CWD.
The likelihood of successful interspecies transmission
of prion diseases is influenced by the degree of homology
of the infecting prion with that of the host endogenous
prion protein. Such observations have given rise to the con-
cept of a “species barrier,” which would need to be over-
come before an infecting prion strain caused disease in a
recipient host. In vitro cell-free conversion reaction experi-
ments have been developed to assess the degree of molec-
ular compatibility of disease-associated prions from one
species with normal prion protein obtained from a different
species (44,45). Such experiments specifically assess the
likelihood that an infecting prion would potentially initiate
the formation and propagation of pathogenic prions if it
came in contact with normal prion protein. A cell-free con-
version experiment indicated that CWD-associated prions
can convert human prion protein into its abnormal con-
former, albeit at a very low rate (44). The efficiency of this
conversion was >14-fold weaker than the homologous con-
version of cervid prion protein and >5-fold weaker than the
homologous conversion induced by CJD-associated prions.
Asimilar low efficiency conversion of human prion protein
by bovine- and scrapie-associated prions was also reported
(44,45). Although a high level of compatibility of prions in
in vitro conversion reactions is believed to correlate with in
vivo transmissibility of the agents, the threshold of compat-
ibility efficiency below which no natural transmission
should be anticipated is unknown. A low level of compati-
bility of infecting prions and host prion protein does not
necessarily rule in or out natural interspecies transmission
of prion diseases. However, the comparably low-level in
vitro conversion of bovine prion protein by CWD-associat-
ed prions is consistent with the relative in vivo resistance of
cattle to CWD under all but the most extreme experimental
challenges. In addition, several other factors may determine
the in vivo transmission of disease-associated prions,
including dose, strain of the agent, route of infection, stabil-
ity of the agent inside and outside the host, and the efficien-
cy of agent delivery to the nervous system (44,46).
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The lack of evidence of a link between CWD transmis-
sion and unusual cases of CJD, despite several epidemio-
logic investigations, and the absence of an increase in CJD
incidence in Colorado and Wyoming suggest that the risk,
if any, of transmission of CWD to humans is low. Although
the in vitro studies indicating inefficient conversion of
human prion protein by CWD-associated prions raise the
possibility of low-level transmission of CWD to humans,
no human cases of prion disease with strong evidence of a
link with CWD have been identified. However, the trans-
mission of BSE to humans and the resulting vCJD indicate
that, provided sufficient exposure, the species barrier may
not completely protect humans from animal prion diseases.
Because CWD has occurred in a limited geographic area
for decades, an adequate number of people may not have
been exposed to the CWD agent to result in a clinically
recognizable human disease. The level and frequency of
human exposure to the CWD agent may increase with the
spread of CWD in the United States. Because the number
of studies seeking evidence for CWD transmission to
humans is limited, more epidemiologic and laboratory
studies should be conducted to monitor the possibility of
such transmissions. Studies involving transgenic mice
expressing human and cervid prion protein are in progress
to further assess the potential for the CWD agent to cause
human disease. Epidemiologic studies have also been ini-
tiated to identify human cases of prion disease among per-
sons with an increased risk for exposure to potentially
CWD-infected deer or elk meat (47). If such cases are
identified, laboratory data showing similarities of the etio-
logic agent to that of the CWD agent would strengthen the
conclusion for a causal link. Surveillance for human prion
diseases, particularly in areas where CWD has been detect-
ed, remains important to effectively monitor the possible
transmission of CWD to humans. Because of the long
incubation period associated with prion diseases, convinc-
ing negative results from epidemiologic and experimental
laboratory studies would likely require years of follow-up.
In the meantime, to minimize the risk for exposure to the
CWD agent, hunters should consult with their state
wildlife agencies to identify areas where CWD occurs and
continue to follow advice provided by public health and
wildlife agencies. Hunters should avoid eating meat from
deer and elk that look sick or test positive for CWD. They
should wear gloves when field-dressing carcasses, bone-
out the meat from the animal, and minimize handling of
brain and spinal cord tissues. As a precaution, hunters
should avoid eating deer and elk tissues known to harbor
the CWD agent (e.g., brain, spinal cord, eyes, spleen, ton-
sils, lymph nodes) from areas where CWD has been iden-
tified.
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